TF and Schnyder corneal dystrophy: Collectively, these studies implicate TF as a critical mediator of vascular inflammation and thrombotic end-organ damage in murine models of SCD and suggest that appropriately targeted anticoagulation treatment might lead to improved clinical outcomes in sickle cell patients.